NCT02484690 · Interventional trial
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Overall registry status Completed
Phase 2
Conditions Choroidal Neovascularization
Delaware Valley sites
- Mid Atlantic Retina · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory